Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Moderate to Severe Hidradenitis Suppurativa
NCT01468233Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2011
- Primary completion
- Apr 2014
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in hidradenitis suppurativa (HS), sponsored by AbbVie Inc.. Started Nov 2011; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT01468233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468233.